Posted on 12 月 5, 202412/5/24
From R&D to ROI: AI’s impact on pharma commercialisation
Posted on 12 月 2, 202412/2/24
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer
Posted on 11 月 25, 202411/25/24
What’s Holding Back AI Adoption? Three Insights from Recent Study
Posted on 11 月 20, 202411/20/24
The Increasing Role of AI in Improving the Diagnostic Imaging Landscape
Posted on 10 月 15, 202410/15/24
Digital Innovation and the Direct-To-Patient Model
Posted on 10 月 8, 202410/8/24
OpenAI’s new o1 Series models’ focus on “reasoning” and what it could mean to lifesciences brands and marketers
Posted on 10 月 2, 202410/2/24
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Posted on 9 月 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on 8 月 15, 20248/15/24
Can the Mobile Wave Help Us Navigate the AI Wave?
Posted on 7 月 22, 20247/22/24